Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00369603 · ClinicalTrials.gov registry record · Phase 4
Functional Brain Imaging of Medication Treatment Response in Mild Alzheimer's Disease Patients
A Phase 4 study, sponsored by Duke University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 4
- Enrollment target
NCT00369603: Clinical Trial Phase 4 study, sponsored by Duke University.
NCT00369603 is a Phase 4 study that was terminated before completion, run by Duke University. The registered enrollment target is 4 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00369603, a Phase 4 study, was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether standard medications approved for Alzheimer's disease treatment differ in their action on brain functioning and whether any observed brain activity differences as result of treatment are associated with particular patterns of dementia improvement or reduced decline.
Interventions
- DRUG Aricept
- DRUG Razadyne ER
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2006-10 |
| Est. Completion | 2007-11 |
| Phase | Phase 4 |
Why NCT00369603 stopped before completion
NCT00369603 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Aricept is the first listed.
NCT00369603 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00369603 about?
NCT00369603 is a clinical study titled "Functional Brain Imaging of Medication Treatment Response in Mild Alzheimer's Disease Patients". The purpose of this study is to determine whether standard medications approved for Alzheimer's disease treatment differ in their action on brain functioning and whether any observed brain activity differences as result of treatment are associated with particular patterns of dementia improvement or ...
What is the current status of trial NCT00369603?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 4 participants. The study started on 2006-10. Estimated completion is 2007-11.
What interventions are being tested in trial NCT00369603?
The interventions under investigation include: Aricept (DRUG), Razadyne ER (DRUG).
Who is sponsoring clinical trial NCT00369603?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00369603's enrollment target sits among peer trials
4 1994th of 2000 higher than 6 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia